Stephen Maxted Ansell, MD, PhD

  • 20573 Citations
  • 76 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1983 2019

Filter
Letter
2019

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas

Ellin, F., Maurer, M. J., Srour, L., Farooq, U., Jerkeman, M., Connors, J. M., Smedby, K. E., Bennani, N., Ansell, S. M., Slack, G. W., Cerhan, J. R., Relander, T., Feldman, A. L. & Savage, K. J., Jan 1 2019, In : British journal of haematology.

Research output: Contribution to journalLetter

Open Access
Peripheral T-Cell Lymphoma
2018
3 Citations (Scopus)

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts

Ghesquières, H., Larrabee, B. R., Casasnovas, O., Maurer, M. J., McKay, J. D., Ansell, S. M., Montgomery, D., Asmann, Y., Farrell, K., Verney, A., Slager, S. L., Allmer, C., Perrot, A., Delarue, R., Habermann, T. M., Dupuis, J., Link, B. K., Canioni, D., Dogan, A., Cozen, W. & 3 others, Jarrett, R. F., Cerhan, J. R. & Salles, G., Jan 1 2018, In : British Journal of Haematology. 180, 2, p. 286-290 5 p.

Research output: Contribution to journalLetter

Leupeptins
Long Noncoding RNA
Chromosomes, Human, Pair 8
myc Genes
Genetic Loci

In reply

Kapoor, P., Gertz, M. & Ansell, S. M., May 1 2018, In : JAMA oncology. 4, 5, p. 745-746 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Reply to Castillo et al.

Abeykoon, J. P., King, R., Ansell, S. M., Rajkumar, S. V., Paludo, J., Kyle, R. A., Kumar, S. K., Gertz, M. & Kapoor, P., Mar 1 2018, In : American Journal of Hematology. 93, 3, p. E71-E73

Research output: Contribution to journalLetter

2017
1 Citation (Scopus)

First report of MYD88L265P somatic mutation in IgM-associated light chain amyloidosis

Chakraborty, R., Novak, A. J., Ansell, S. M., Muchtar, E., Kapoor, P., Hayman, S. R., Dispenzieri, A., Buadi, F. K., Lacy, M., King, R. & Gertz, M., Mar 16 2017, In : Amyloid. 24, p. 42-43 2 p.

Research output: Contribution to journalLetter

Amyloidosis
Immunoglobulin M
Light
Mutation
16 Citations (Scopus)

Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma

Connors, J. M., Ansell, S. M., Fanale, M., Park, S. I. & Younes, A., Sep 14 2017, In : Blood. 130, 11, p. 1375-1377 3 p.

Research output: Contribution to journalLetter

Antineoplastic Combined Chemotherapy Protocols
Immunoconjugates
Molecular Targeted Therapy
Remission Induction
Dacarbazine
4 Citations (Scopus)
Exome
Lymphoma, Large B-Cell, Diffuse
2016
9 Citations (Scopus)

First report of MYD88L265P somatic mutation in IgM-associated light-chain amyloidosis

Chakraborty, R., Novak, A. J., Ansell, S. M., Muchtar, E., Kapoor, P., Hayman, S. R., Dispenzieri, A., Buadi, F. K., Lacy, M., King, R. & Gertz, M., Jun 9 2016, In : Blood. 127, 23, p. 2936-2938 3 p.

Research output: Contribution to journalLetter

Myeloid Differentiation Factor 88
Amyloidosis
Survival Analysis
Point Mutation
Immunoglobulin M